We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.0% | 56.00 | 3,932 | 07:49:57 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 55.00 | 57.00 | 56.00 | 56.00 | 56.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 24.48M | -2.7M | -0.0382 | -14.66 | 39.52M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 12:03:14 | O | 82 | 55.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/11/2023 | 16:36 | UKREG | Tissue Regenix Group PLC Holding(s) in Company |
| 30/10/2023 | 14:31 | ALNC |  TRADING UPDATES: Solid State expects higher annual revenue |
| 30/10/2023 | 07:00 | UKREG | Tissue Regenix Group PLC HPRA approval & distribution agreement in Spain |
| 15/9/2023 | 15:30 | UKREG | Tissue Regenix Group PLC Director/PDMR Shareholding |
| 05/9/2023 | 10:50 | ALNC | Tissue Regenix loss narrows on higher revenue; launches BioRinse |
| 05/9/2023 | 06:01 | UKREG | Tissue Regenix Group PLC New sports medicine product launch |
| 05/9/2023 | 06:00 | UKREG | Tissue Regenix Group PLC Interim results |
| 31/8/2023 | 18:05 | UKREG | Tissue Regenix Group PLC Exercise of Options and Total Voting Rights |
| 21/8/2023 | 06:00 | UKREG | Tissue Regenix Group PLC Notice of interim results |
| 17/7/2023 | 14:49 | ALNC | TRADING UPDATES: Beacon sees delays; Churchill China trades in line |
Tissue Regenix (TRX) Share Charts1 Year Tissue Regenix Chart |
|
1 Month Tissue Regenix Chart |
Intraday Tissue Regenix Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2023 | 18:11 | Tissue Regenix delivering practical solutions to real clinical issues | 7,745 |
| 27/9/2021 | 17:42 | Tissue Regenix takes pole position in regeneration game | 2 |
| 26/5/2020 | 12:31 | Torex with Charts & News | 14 |
| 15/1/2020 | 07:09 | TOREX 2007 - THE TILLS RING AT LAST | 13 |
| 14/1/2020 | 20:51 | Terrane Minerals- Cu explorer, trading in Canada | 17 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 12:03:15 | 55.00 | 82 | 45.10 | O |
| 11:01:39 | 55.00 | 1,000 | 550.00 | O |
| 11:00:14 | 54.00 | 1,700 | 918.00 | UT |
| 08:26:13 | 55.00 | 93 | 51.15 | O |
| 08:26:13 | 55.00 | 1,032 | 567.60 | O |
| Top Posts |
|---|
Posted at 01/12/2023 08:20 by Tissue Regenix Daily Update Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 56p.Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £39,521,702. Tissue Regenix has a price to earnings ratio (PE ratio) of -14.66. This morning TRX shares opened at 56p |
Posted at 31/10/2023 14:52 by mickhay3 Trading view trx https://ibb.co/jgDtz |
Posted at 06/9/2023 13:41 by p1nkfish Do enough research and the gaps TRX can plug for STRYKER are obvious. Pocket change to them too. |
Posted at 05/9/2023 06:47 by cliffpeat @tnt99re: "takeover target" - the Chairman's statement on the interims appears to be "setting out the stall" saying: "We have created a commercially focussed global regenerative medtech company in a high-growth sector focused on soft tissues and bone, with a multi-billion-dollar addressable market opportunity in the United States ('US') alone." Could you share your workings supporting your suggestion of a potential 2024 profit of $8-10m and what % level of growth (compared to H1) would be required? The balance sheet shows high inventory, trade debtors and intangibles - and constant reference to EBITDA might be a red flag for some. Will be interesting to see whether the positive H1 results today move the share price at all. |
Posted at 05/9/2023 06:24 by tnt99 With this sort of growth must become a takeover target now we should finally see a re rate to the share price Must be over 1.00 pound by ChristmasAnd the potential for a 8-10 million profit next year and an expected market cap over 100 millionThat's my thoughts It's been a long road though !! |
Posted at 04/9/2023 14:03 by tnt99 The path to profitability has been achieved and I hope the figure of between 1 and 3 million profit is made in the results tomorrow Any better should see a jump in the share price |
Posted at 31/8/2023 07:41 by p1nkfish Collateralized loan note.It's a loan that pays interest and/or issues share in the company in exchange for the lender taking part. There can be a redemption date where the borrowing is paid back via issued shares, or some per year. The exact terms vary depending on the borrower and they can vary widely. The lenders can be offered a variety of ways to achieve a benefit. Sometimes the major shareholders influence how it is packaged. It is not the same as issuing discounted shares into the market. I took part in the CRX offering and TRX might make a decent candidate for raising that way especially given the share register. From memory Mills (Harwood), Sneller (Inthallo) and Griffiths were all on the CRX register and took part. Guess who is on the TRX register. |
Posted at 17/7/2023 07:55 by tnt99 Should as I say mean a maiden profit this year and the Australian deal should add to the the year end nicely Hope to see the share price going in the same direction after very little uplift on the news??!! |
Posted at 27/3/2023 15:04 by clocktower The chart is not looking good either is it ?Once consolidated I expect it to slide further as liquidity drys up. I could understand it if they had already turned to a profitable business and if the share price was over 2p with a strong forward statement but not now. You may harp on how good this is but the facts of the slide in share price speaks volumes. I will even revise my target down now. |
Posted at 23/3/2023 15:53 by timmy40 Sorry I cannot see this back at 0.50, the results were positive with +20% revenue across all divisions + cash in the bank to get to break even. The company is growing revenue in existing markets, particularly the US, as elective surgeries return/increase in frequency after Covid. They are expanding to new geographies/markets too, most probably China/Asia in the near future.The consolidation is required given the share price/no of shares in issue. A higher share price will mean the company is more marketable to institutions. It is v common in the US, which is the largest market by far for TRX and their board are Americans ? There is no dilution overall. This is all v good news. TRX's management are doing an excellent job but just imo. |
Posted at 11/8/2022 10:11 by livewireplus :-)) unfortunately no refunds ... but had some good times ... have ended-up married - but as wife earns more than me then can't complain .... pass the Tissue from the left-hand side. An interesting week so far for the TRX share price .... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
